Cyclothiazide
Clinical data | |
---|---|
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Cyclothiazide (Anhydron, Acquirel, Doburil, Fluidil, Renazide, Tensodiural, Valmiran), sometimes abbreviated CTZ, is a
antihypertensive that was originally introduced in the United States in 1963 by Eli Lilly and was subsequently also marketed in Europe and Japan.[1][2] Related drugs include diazoxide, hydrochlorothiazide, and chlorothiazide.[3]
In 1993, it was discovered that cyclothiazide is a
epileptiform activity and inducing seizures, but without producing any apparent neuronal death.[8][9]
Cyclothiazide has been found to act as a
Synthesis
See also
References
- ISBN 978-3-88763-075-1.
- ISBN 978-0-8155-1144-1.
- ^ ISBN 978-0-8493-8307-6.
- PMID 8103555.
- PMID 7915948.
- ISBN 978-3-540-22568-3.
- PMID 14534329.
- PMID 16423850.
- PMID 20678492.
- ^ PMID 17095021.
- .
- ^ US 3275625, Müller E, Hasspacher K, issued 1966, assigned to Boehringer Ingelheim